RadNet, Inc. (RDNT)
| Market Cap | 1.22B |
| Revenue (ttm) | 1.11B |
| Net Income (ttm) | 10.98M |
| Shares Out | 51.95M |
| EPS (ttm) | -0.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 11 |
| Last Price | $22.71 |
| Previous Close | $22.80 |
| Change ($) | -0.09 |
| Change (%) | -0.39% |
| Day's Open | 22.84 |
| Day's Range | 22.71 - 23.31 |
| Day's Volume | 9,304 |
| 52-Week Range | 12.80 - 25.49 |
RadNet (RDNT) delivered earnings and revenue surprises of 180.00% and 7.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of RadNet (NASDAQ:RDNT) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share increased 112.12% year over year to $0.04, which beat the estimate of ($0.03).
LOS ANGELES, May 10, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a networ...
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GREENVILLE, S.C., May 3, 2021 /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), a leading provider of RIS (Radiology Information System) and PACS (Picture Archiving and Communication Sy...
LOS ANGELES, April 29, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operat...
LOS ANGELES, April 26, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and/or ope...
RadNet (RDNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CAMBRIDGE, Mass. and LOS ANGELES, April 19, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc., (NASDAQ: RDNT) today announced that its subsidiary DeepHealth, a leading developer of artificial intelligence (AI) for ...
LOS ANGELES, April 06, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and/or ope...
LOS ANGELES, March 17, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and ...
RadNet (RDNT) delivered earnings and revenue surprises of 25.00% and 1.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
LOS ANGELES, March 08, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw...
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOS ANGELES, Feb. 23, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operate...
Nation's Largest Radiology Firm Signs Long-Term Lease for 24,000 Square Foot Space In Park Central's Strauss Building; Adds to Medical and Tech Presence in Project Nation's Largest Radiology Firm Signs ...
CAMBRIDGE, Mass. and LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) today reported that its DeepHealth subsidiary, a leading developer of artificial intelligence (AI) for mam...
GREENVILLE, S.C., Nov. 30, 2020 /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), a leading provider of radiology image and data management software solutions, announced today that Hutc...
LOS ANGELES, Nov. 25, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and o...
GREENVILLE, S.C., Nov. 10, 2020 /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), a leading provider of radiology image and data management software solutions, announced today that Adva...
RadNet, Inc. (RDNT) CEO Howard Berger on Q3 2020 Results - Earnings Call Transcript
RadNet (RDNT) delivered earnings and revenue surprises of 350.00% and 12.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
LOS ANGELES, Nov. 09, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netwo...
LOS ANGELES, Nov. 05, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and o...
LOS ANGELES, Oct. 30, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operate...
LOS ANGELES, Oct. 27, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported ...
LOS ANGELES, Oct. 20, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported ...
RadNet (RDNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LOS ANGELES, Sept. 22, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an...
LOS ANGELES, Aug. 31, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a net...
RadNet (RDNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RadNet, Inc. (RDNT) CEO Howard Berger on Q2 2020 Results - Earnings Call Transcript
RadNet (RDNT) delivered earnings and revenue surprises of 61.90% and 3.18%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
LOS ANGELES, Aug. 10, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a net...
Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technology Collaboration will include data sharing, R&D and an up...
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOS ANGELES, July 28, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and opera...
RadNet, Inc. (RDNT) CEO Howard Berger on Q1 2020 Results - Earnings Call Transcript
Shares of RadNet (NASDAQ:RDNT) remained unaffected at $14.43 after the company reported Q1 results.
RadNet (RDNT) delivered earnings and revenue surprises of 2.94% and 6.08%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...
RadNet, Inc. (RDNT) CEO Howard Berger on Q4 2019 Results - Earnings Call Transcript
RadNet (RDNT) delivered earnings and revenue surprises of 40.00% and 2.70%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TORONTO, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”), a commercial-stage medical device company focused on customizable, incision-free...
LOS ANGELES, Jan. 10, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reporte...
RadNet (RDNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RadNet (RDNT) is optimistic about maintaining momentum on several positive developments.
Shares pop after news breaks that the company is joining an index. Here are the key details for investors.
RadNet, Inc. (RDNT) CEO Howard Berger on Q3 2019 Results - Earnings Call Transcript
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems. As of March 8, 2021, it owned and/or... [Read more...]
| Industry Diagnostics & Research | IPO Date Jul 1, 1986 |
| CEO Howard Berger | Employees 6,157 |
| Stock Exchange NASDAQ | Ticker Symbol RDNT |
Analyst Forecasts
According to 3 analysts, the average rating for RadNet stock is "Strong Buy." The 12-month stock price forecast is 27.33, which is an increase of 20.34% from the latest price.